Page last updated: 2024-09-04

embusartan and angiotensin ii

embusartan has been researched along with angiotensin ii in 6 studies

Compound Research Comparison

Studies (embusartan)	Trials (embusartan)	Recent Studies (post-2010) (embusartan)	Studies (angiotensin ii)	Trials (angiotensin ii)	Recent Studies (post-2010) (angiotensin ii)
8	1	0	38,152	1,089	7,413

Protein Interaction Comparison

Protein	Taxonomy	angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3	Homo sapiens (human)	0.002
Type-1A angiotensin II receptor	Rattus norvegicus (Norway rat)	0.002
Type-1B angiotensin II receptor	Rattus norvegicus (Norway rat)	0.0018
Type-1 angiotensin II receptor	Homo sapiens (human)	0.0055
Type-2 angiotensin II receptor	Rattus norvegicus (Norway rat)	0.004
Type-2 angiotensin II receptor	Homo sapiens (human)	0.0011

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (66.67)	18.2507
2000's	2 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böhm, M; Ettelbrück, S; Flesch, M; Knorr, A; Pinto, Y; Schiffer, F; Stasch, JP; Zolk, O	1
Beuck, M; Dressel, J; Fey, P; Frobel, K; Hirth-Dietrich, C; Hübsch, W; Kazda, S; Knorr, A; Krämer, T; Sander, E; Stasch, JP	1
Belz, GG; Breithaupt-Grögler, K; Butzer, R; Herrmann, V; Malerczyk, C; Stass, H; Wensing, G	1
Iouzalen, L; Marche, P; Stepien, O	1
Leenen, FH; Zhang, J	1
Balt, JC; Mathy, MJ; Pfaffendorf, M; van Zwieten, PA	1

Trials

1 trial(s) available for embusartan and angiotensin ii

Article	Year
Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man. International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:10 Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Humans; Infusions, Intravenous; Male; Regression Analysis; Tetrazoles; Vasoconstrictor Agents	1997

Article

Year

Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.

International journal of clinical pharmacology and therapeutics, 1997, Volume: 35, Issue:10

Topics: Administration, Oral; Adult; Angiotensin II; Angiotensin Receptor Antagonists; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Humans; Infusions, Intravenous; Male; Regression Analysis; Tetrazoles; Vasoconstrictor Agents

1997

Other Studies

5 other study(ies) available for embusartan and angiotensin ii

Article	Year
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. Journal of hypertension, 1997, Volume: 15, Issue:9 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blotting, Northern; Blotting, Western; Calcium-Transporting ATPases; Captopril; Cardiomyopathy, Hypertrophic; Diastole; Dihydropyridines; Disease Models, Animal; Heart Ventricles; Hemodynamics; Hypertension; Mice; Mice, Transgenic; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sarcoplasmic Reticulum; Tetrazoles	1997
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats. Arzneimittel-Forschung, 1997, Volume: 47, Issue:9 Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modified; Antihypertensive Agents; Atrial Natriuretic Factor; Body Weight; Cerebrovascular Disorders; Cyclic GMP; Dihydropyridines; Hemodynamics; Hormones; Hypertension; Kidney; Rats; Rats, Inbred SHR; Renin; Tetrazoles	1997
Effects of BAY 10-6734 (Embusartan), a new angiotensin II type I receptor antagonist, on vascular smooth muscle cell growth. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cell Division; Cells, Cultured; Cytosol; Dihydropyridines; DNA; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Protein Biosynthesis; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Species Specificity; Tetrazoles	1999
Peripheral administration of AT1 receptor blockers and pressor responses to central angiotensin II and sodium. Canadian journal of physiology and pharmacology, 2001, Volume: 79, Issue:10 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Dihydropyridines; Dose-Response Relationship, Drug; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Losartan; Male; Peripheral Nervous System; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sodium; Tetrazoles	2001
Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan. Journal of hypertension, 2001, Volume: 19, Issue:12 Topics: Acrylates; Adrenergic alpha-Agonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dihydropyridines; Dose-Response Relationship, Drug; Imidazoles; Male; Norepinephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Thiophenes; Valine; Valsartan	2001